Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
American Oncology Network, Inc. - Class A Common Stock
(NQ:
AONC
)
2.140
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about American Oncology Network, Inc. - Class A Common Stock
< Previous
1
2
Next >
American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research
Today 8:00 EST
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Welcomes Robert J. McDonald, MD, FACNM, as Radiology Medical Director and In-House Reading Radiologist
December 10, 2025
Dr. McDonald’s Role Supports AON’s Growth in Radiotheranostics and Network-Wide RLT Capabilities
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Presents 15 Research Abstracts at ASCO Quality 2025
October 10, 2025
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Reports Strong Growth and Record Milestones in 2025
August 12, 2025
Annual revenue surpasses $2 billion for the 12 months ended June 30, 2025, reflecting >40% growth over the prior 12-month period. Provider network grows to >300 across 20 states. New treatment...
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Central Lab Receives Reaccreditation from College of American Pathologists
July 24, 2025
From
American Oncology Network
Via
GlobeNewswire
More Than 40 American Oncology Network Clinics Across 18 States and Washington, D.C., Now Offering Bispecific T-cell Engager Therapies to Patients
July 22, 2025
AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard-to-treat cancers
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Announces Research Studies Presented at ASCO 2025 Annual Meeting
June 03, 2025
Several AON physicians and leaders shared new cancer research at one of oncology’s most influential gatherings
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Expands Access to Advanced Radioligand Therapies Across U.S. Network
May 21, 2025
Six AON community oncology practice partners now offering radioligand therapeutics for prostate and neuroendocrine cancers
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Appoints Joe Verschleiser as Chief Growth and Performance Officer
May 15, 2025
From
American Oncology Network
Via
GlobeNewswire
Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)
May 14, 2025
Sakeer Hussain, MD, was honored for his dedication to advancing cancer policy at national and state levels during ASCO’s 2025 Advocacy Summit event
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Appoints Terri Casey as Chief Human Resources Officer
May 13, 2025
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network to Participate in 14 Sessions at 2025 Community Oncology Alliance Annual Conference
April 24, 2025
More than a dozen AON leaders to speak on panels focused on advocacy, innovation and access in independent community oncology
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Achieves Success in First Performance Period of CMMI’s Enhancing Oncology Model
April 22, 2025
Strategic Thyme Care partnership strengthens AON’s leadership in value-based care innovation while improving patient experience and reducing costs
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Launches Cloud-Based Laboratory Information System to Streamline Pathology Reporting for Oncologists
February 25, 2025
SigmaCore’s easy-to-use platform, LabVizor integrates complex pathology reports into a streamlined, comprehensive system to enhance efficiency for AON’s pathology and oncology labs
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network (AON) and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform
October 29, 2024
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Announces Second Quarter 2024 Earnings Release Date and Conference Call
July 31, 2024
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Announces the Commencement of OTCQX Trading
June 10, 2024
From
American Oncology Network
Via
GlobeNewswire
Florida Oncology and Hematology and American Oncology Network Opens New Location in Cape Coral, Welcomes Medical Director, Dr. Van den Bergh, and Drs. Venkata Parsa, and Shivtaj Mann
October 22, 2024
Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO join the Cape Coral physician team
From
American Oncology Network
Via
GlobeNewswire
OTC Markets Group Welcomes American Oncology Network, Inc. to OTCQX
June 10, 2024
From
OTC Markets
Via
GlobeNewswire
American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer
June 03, 2024
Veteran Financial Leader David Afshar will lead the company’s financial and operating strategy.
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Announces Voluntary Delisting From Nasdaq
May 21, 2024
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network, Inc. Announces First Quarter 2024 Financial Results
May 15, 2024
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Announces Date Change for First Quarter 2024 Earnings Release Date and Conference Call
May 14, 2024
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Announces CFO Transition
May 03, 2024
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Announces First Quarter 2024 Earnings Release Date and Conference Call
April 30, 2024
From
American Oncology Network
Via
GlobeNewswire
Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery
April 04, 2024
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Expands to Hawaii, Welcomes New Practice to Network
April 03, 2024
Hawaii Cancer Care partners with American Oncology Network to continue delivering quality cancer care to the community.
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network, Inc. (“AON”) Announces Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Expands Footprint in Texas with the Addition of Woodlands Cancer Institute in Houston
March 26, 2024
Woodlands Cancer Institute opens three clinic locations that provide medical oncology, radiation oncology and hematology care to its patients.
From
American Oncology Network
Via
GlobeNewswire
American Oncology Network Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
March 06, 2024
From
American Oncology Network
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.